These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 16900171

  • 1. Silent running: the race to the clinic.
    Nature; 2006 Aug 10; 442(7103):614-5. PubMed ID: 16900171
    [No Abstract] [Full Text] [Related]

  • 2. Biotech's wonder ride.
    Rynecki D.
    Fortune; 2000 Mar 06; 141(5):435-6. PubMed ID: 10788046
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The stampede to convertibles.
    Jacobs T.
    Nat Biotechnol; 2003 Aug 06; 21(8):855. PubMed ID: 12894195
    [No Abstract] [Full Text] [Related]

  • 5. Biotechs hold their own in shifting industry.
    Mitchell P.
    Nat Biotechnol; 2002 Nov 06; 20(11):1065-6. PubMed ID: 12410238
    [No Abstract] [Full Text] [Related]

  • 6. Any diamonds in the diagnostic coal?
    Jacobs T.
    Nat Biotechnol; 2006 Aug 06; 24(8):930. PubMed ID: 16900133
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Early-stage returns?
    Booth BL.
    Nat Biotechnol; 2006 Nov 06; 24(11):1335-40. PubMed ID: 17093473
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Little biotech on the prairie.
    Wolfson W.
    Chem Biol; 2007 Sep 06; 14(9):969-71. PubMed ID: 17884626
    [No Abstract] [Full Text] [Related]

  • 12. Biotech slumps in Q1.
    Lawrence S.
    Nat Biotechnol; 2008 May 06; 26(5):486. PubMed ID: 18464769
    [No Abstract] [Full Text] [Related]

  • 13. Betting on biogenerics.
    Dove A.
    Nat Biotechnol; 2001 Feb 06; 19(2):117-20. PubMed ID: 11175723
    [No Abstract] [Full Text] [Related]

  • 14. Shutters come off IPO window.
    Hodgson J.
    Nat Biotechnol; 2002 Jan 06; 20(1):6. PubMed ID: 11753342
    [No Abstract] [Full Text] [Related]

  • 15. Divining the path to a successful European exit.
    Buch HK, Gustafsson AC, Drvota V, Sundberg CJ.
    Nat Biotechnol; 2011 Mar 06; 29(3):205-7. PubMed ID: 21510008
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. 25 top health care stocks. Will they lead the next market boom?
    Kane L.
    Med Econ; 2001 Apr 09; 78(7):126-8, 133-6, 140-2. PubMed ID: 11368040
    [No Abstract] [Full Text] [Related]

  • 19. Biotechnology in the Medicon Valley.
    Frank L.
    Nature; 2002 Dec 12; 420(6916 Suppl):A27, A29, A31 passim. PubMed ID: 12501124
    [No Abstract] [Full Text] [Related]

  • 20. The 802 million dollars fallacy.
    Hodgson J.
    Nat Biotechnol; 2004 Sep 12; 22(9):1076. PubMed ID: 15340464
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.